Subcutaneously implanted central venous access devices in cancer patients

Schwarz, Roderich E.; Groeger, Jeffrey S.; Coit, Daniel G.

doi:10.1002/(sici)1097-0142(19970415)79:8<1635::aid-cncr30>3.3.co;2-4

Cited by 22 publications

(23 citation statements)

References 1 publication

Supporting

Mentioning

Contrasting

Order By: Relevance

“…[10,11] Infectious complications with TIVAPs in the range of 4.8-8.8% have been reported in the literature. [12,13] In a prospective study of 680 patients between June 1987 and May 1989 at Memorial Sloan-Kettering Cancer Center, followed up until port removal, death, or a maximum of 1960 days, infectious complications were noted in 8.8% of patients, half of which were surgical site infections and rest were systemic sepsis. [12] Biffi et al in a study of 376 patients found 3 patients who suffered from port-related bacteremia (0.8%, 0.016/1000 days of use).…”

Section: Discussionmentioning

confidence: 99%

“…[12,13] In a prospective study of 680 patients between June 1987 and May 1989 at Memorial Sloan-Kettering Cancer Center, followed up until port removal, death, or a maximum of 1960 days, infectious complications were noted in 8.8% of patients, half of which were surgical site infections and rest were systemic sepsis. [12] Biffi et al in a study of 376 patients found 3 patients who suffered from port-related bacteremia (0.8%, 0.016/1000 days of use). [14] In our study, we observed 7 (8.64%) patients with infection with the port in situ, 5 of whom required the removal of the ports.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Totally implantable venous access ports: Retrospective review of long-term complications in 81 patients

Bassi¹,

Giri²,

Pattanayak³

et al. 2012

Indian J Cancer

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Totally implantable venous access ports: Retrospective review of long-term complications in 81 patients

Bassi¹,

Giri²,

Pattanayak³

et al. 2012

Indian J Cancer

View full text Add to dashboard Cite

show abstract

“…Considering that literature rates of subcutaneous pocket infection ranged from 4.8% to 8.8% and its occurrence is more common after 20 weeks of implant , the short period of follow up in this study may have been insufficient to detect the total number of pocket infections.…”

Section: Discussionmentioning

confidence: 92%

Evaluation of three different techniques for insertion of totally implantable venous access device: A randomized clinical trial

et al. 2015

View full text Add to dashboard Cite

show abstract

“…Currently, over 200 000 ports are implanted in the United States each year, and their popularity is increasing. Vascular access ports have been proved to be very beneficial in overcoming the need for frequent venipuncture in the treatment of long‐term venous therapies (5,6) .…”

mentioning

confidence: 99%

A randomized prospective study of comparison of reservoir ports versus conventional vascular access in advanced-stage ovarian carcinoma cases treated with chemotherapy

Şehirali¹,

İnal²,

Özsezgin³

et al. 2005

Int J Gynecol Cancer

View full text Add to dashboard Cite

Vascular access ports were developed to overcome many of the problems associated with limited peripheral access, combined with the need for frequent venipuncture, in oncology patients receiving long-term intensive therapy. In this study, we compared the effectivity and acceptability of vascular access port with conventional needle application together with complication rates in ovarian cancer patients. Advanced-stage ovarian carcinoma cases under chemotherapy treatment were equally randomized into two groups, implantable vascular access ports applied to one group (22 cases) and conventional vascular access applied to the other (38 cases) as a control group. Anteroposterior thoracic X-rays of implantable port-applied cases were taken before and after the application. Vortex reservoir ports (Horizon Medical Products, Inc., Manchester, GA) were used in the application to the subclavian vein. Classic peripheral venipuncture method (Medikit), Mediflon(trade mark) IV cannula with PTFE radiopaque catheter and injection valve, Eastern Medikit Ltd, Gurgaon, Haryana, India) was used in the control group. Vascular accesses of all cases were controlled just after the application, 12 h after the application, and during each drug or intravenous fluid application. Mean port insertion time was 26.3 min. Total port occlusion was observed in two of the port-applied cases (11.7%) and partial port occlusion was observed in five of the port-applied cases (29%). Heparin and saline combination was used in order to open the port tip, in five cases, two with total occlusion and three with partial occlusion. Infection was observed in only one case (5%) to whom appropriate therapy was given, and the port was taken out. Ports of two cases were also taken out because of skin dehiscence. No change in port tip position was observed in any of the cases. Total occlusion was observed in 16 of the 38 cases (42.1%) with conventional vascular access. In 12 cases (31.5%), a need arose to change the conventional vascular access. No vascular access was found in 13 of the 38 cases (34.2%). Application of reservoir ports especially to cases with advanced-stage carcinomas, under chemotherapeutic drug treatment, leads to minimal anxiety for the patient and his/her family and minimal risk of physical trauma to the patient with only one vascular access. Reservoir ports occlude or cause infection to a lesser extent than classic vascular access methods. Occlusion or infection rates of reservoir ports are statistically significant, lower than those of classic venipuncture.

show abstract

Subcutaneously implanted central venous access devices in cancer patients

Cited by 22 publications

References 1 publication

Totally implantable venous access ports: Retrospective review of long-term complications in 81 patients

Totally implantable venous access ports: Retrospective review of long-term complications in 81 patients

Evaluation of three different techniques for insertion of totally implantable venous access device: A randomized clinical trial

A randomized prospective study of comparison of reservoir ports versus conventional vascular access in advanced-stage ovarian carcinoma cases treated with chemotherapy

Contact Info

Product

Resources

About